Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2016, Article ID 1261270, 8 pages
http://dx.doi.org/10.1155/2016/1261270
Research Article

Ferulic Acid against Cyclophosphamide-Induced Heart Toxicity in Mice by Inhibiting NF-κB Pathway

1Department of Cardiology, The Second Affiliated Hospital, Medical School of Xi’an Jiaotong University, Xi’an 710004, China
2Department of Oncology, The Central Hospital of Xi’an, Xi’an 710003, China
3Department of Oncology, The Second Affiliated Hospital, Medical School of Xi’an Jiaotong University, Xi’an 710004, China

Received 12 August 2015; Accepted 17 September 2015

Academic Editor: Roberto Miniero

Copyright © 2016 Yafan Song et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. K. K. Bass and M. J. Mastrangelo, “Immunopotentiation with low-dose cyclophosphamide in the active specific immunotherapy of cancer,” Cancer Immunology Immunotherapy, vol. 47, no. 1, pp. 1–12, 1998. View at Publisher · View at Google Scholar · View at Scopus
  2. M. L. Salem, A. A. Al-Khami, S. A. El-Naggar, C. M. Díaz-Montero, Y. Chen, and D. J. Cole, “Cyclophosphamide induces dynamic alterations in the host microenvironments resulting in a Flt3 ligand-dependent expansion of dendritic cells,” Journal of Immunology, vol. 184, no. 4, pp. 1737–1747, 2010. View at Publisher · View at Google Scholar · View at Scopus
  3. M. L. Salem, C. M. Díaz-Montero, A. A. Al-Khami et al., “Recovery from cyclophosphamide-induced lymphopenia results in expansion of immature dendritic cells which can mediate enhanced prime-boost vaccination antitumor responses in vivo when stimulated with the TLR3 agonist poly(I:C),” The Journal of Immunology, vol. 182, no. 4, pp. 2030–2040, 2009. View at Publisher · View at Google Scholar · View at Scopus
  4. M. Montgomery and M. Cottler-Fox, “Mobilization and collection of autologous hematopoietic progenitor/stem cells,” Clinical Advances in Hematology and Oncology, vol. 5, no. 2, pp. 127–136, 2007. View at Google Scholar · View at Scopus
  5. R. Ochoa, P. A. Bejarano, S. Glück, and A. J. Montero, “Pneumonitis and pulmonary fibrosis in a patient receiving adjuvant docetaxel and cyclophosphamide for stage 3 breast cancer: a case report and literature review,” Journal of Medical Case Reports, vol. 6, article 413, 2012. View at Publisher · View at Google Scholar · View at Scopus
  6. J. D. Shepherd, L. E. Pringle, M. J. Barnett, H.-G. Klingemann, D. E. Reece, and G. L. Phillips, “Mesna versus hyperhydration for the prevention of cyclophosphamide-induced hemorrhagic cystitis in bone marrow transplantation,” Journal of Clinical Oncology, vol. 9, no. 11, pp. 2016–2020, 1991. View at Google Scholar · View at Scopus
  7. R. Paul, P. Kulkarni, and N. Ganesh, “Avocado fruit (Persea americana Mill) exhibits chemo-protective potentiality against cyclophosphamide induced genotoxicity in human lymphocyte culture,” Journal of Experimental Therapeutics and Oncology, vol. 9, no. 3, pp. 221–230, 2011. View at Google Scholar · View at Scopus
  8. H. A. Ozkan, C. Bal, and Z. Gulbas, “Assessment and comparison of acute cardiac toxicity during high-dose cyclophosphamide and high-dose etoposide stem cell mobilization regimens with N-terminal pro-B-type natriuretic peptide,” Transfusion and Apheresis Science, vol. 50, no. 1, pp. 46–52, 2014. View at Publisher · View at Google Scholar · View at Scopus
  9. J. Drímal, J. Zúrová-Nedelcevová, V. Knezl, R. Sotníková, and J. Navarová, “Cardiovascular toxicity of the first line cancer chemotherapeutic agents: doxorubicin, cyclophosphamide, streptozotocin and bevacizumab,” Neuroendocrinology Letters, vol. 27, supplement 2, pp. 176–179, 2006. View at Google Scholar
  10. S. Zver, V. Zadnik, P. Černelč, and M. Koželj, “Cardiac toxicity of high-dose cyclophosphamide and melphalan in patients with multiple myeloma treated with tandem autologous hematopoietic stem cell transplantation,” International Journal of Hematology, vol. 88, no. 2, pp. 227–236, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. X. Chang, H. He, L. Zhu et al., “Protective effect of apigenin on Freund's complete adjuvant-induced arthritis in rats via inhibiting P2X7/NF-κB pathway,” Chemico-Biological Interactions, vol. 236, pp. 41–46, 2015. View at Publisher · View at Google Scholar
  12. X. Liu, L. Wang, H. Li et al., “Coactivator-associated arginine methyltransferase 1 targeted by miR-15a regulates inflammation in acute coronary syndrome,” Atherosclerosis, vol. 233, no. 2, pp. 349–356, 2014. View at Publisher · View at Google Scholar
  13. W. Jiang, F. Luo, Q. Lu et al., “The protective effect of Trillin LPS-induced acute lung injury by the regulations of inflammation and oxidative state,” Chemico-Biological Interactions, 2015. View at Publisher · View at Google Scholar
  14. B. Wei, W.-W. Li, J. Ji, Q.-H. Hu, and H. Ji, “The cardioprotective effect of sodium tanshinone IIA sulfonate and the optimizing of therapeutic time window in myocardial ischemia/reperfusion injury in rats,” Atherosclerosis, vol. 235, no. 2, pp. 318–327, 2014. View at Publisher · View at Google Scholar · View at Scopus
  15. P. Mattila, J. Hellström, and R. Törrönen, “Phenolic acids in berries, fruits, and beverages,” Journal of Agricultural and Food Chemistry, vol. 54, no. 19, pp. 7193–7199, 2006. View at Publisher · View at Google Scholar · View at Scopus
  16. S. Sakai, H. Kawamata, T. Kogure et al., “Inhibitory effect of ferulic acid and isoferulic acid on the production of macrophage inflammatory protein-2 in response to respiratory syncytial virus infection in RAW264.7 cells,” Mediators of Inflammation, vol. 8, no. 3, pp. 173–175, 1999. View at Publisher · View at Google Scholar · View at Scopus
  17. J. Kanski, M. Aksenova, A. Stoyanova, and D. A. Butterfield, “Ferulic acid antioxidant protection against hydroxyl and peroxyl radical oxidation in synaptosomal and neuronal cell culture systems in vitro: structure-activity studies,” Journal of Nutritional Biochemistry, vol. 13, no. 5, pp. 273–281, 2002. View at Publisher · View at Google Scholar · View at Scopus
  18. M. S. Balasubashini, R. Rukkumani, P. Viswanathan, and V. P. Menon, “Ferulic acid alleviates lipid peroxidation in diabetic rats,” Phytotherapy Research, vol. 18, no. 4, pp. 310–314, 2004. View at Publisher · View at Google Scholar · View at Scopus
  19. B. Vashistha, A. Sharma, and V. Jain, “Ameliorative potential of ferulic acid in vincristine-induced painful neuropathy in rats: an evidence of behavioral and biochemical examination,” Nutritional Neuroscience, 2014. View at Publisher · View at Google Scholar
  20. L. Y. Wang, Y. P. Tang, X. Liu et al., “Effects of ferulic acid on antioxidant activity in Angelicae Sinensis Radix, Chuanxiong Rhizoma, and their combination,” Chinese Journal of Natural Medicines, vol. 13, no. 6, pp. 401–408, 2015. View at Publisher · View at Google Scholar
  21. Y.-H. Li, X. Huang, Y. Wang et al., “Pharmacokinetic comparison of the vasorelaxant compound ferulic acid following the administration of Guanxin II to healthy volunteers and patients with angina pectoris,” Experimental and Therapeutic Medicine, vol. 6, no. 5, pp. 1283–1289, 2013. View at Publisher · View at Google Scholar · View at Scopus
  22. Y. Gao, J. Hao, H. Zhang et al., “Protective effect of the combinations of glycyrrhizic, ferulic and cinnamic acid pretreatment on myocardial ischemia-reperfusion injury in rats,” Experimental and Therapeutic Medicine, vol. 9, no. 2, pp. 435–445, 2015. View at Publisher · View at Google Scholar · View at Scopus
  23. S. K. Yogeeta, H. R. B. Raghavendran, A. Gnanapragasam, R. Subhashini, and T. Devaki, “Ferulic acid with ascorbic acid synergistically extenuates the mitochondrial dysfunction during β-adrenergic catecholamine induced cardiotoxicity in rats,” Chemico-Biological Interactions, vol. 163, no. 1-2, pp. 160–169, 2006. View at Publisher · View at Google Scholar · View at Scopus
  24. S. K. Yogeeta, A. Gnanapragasam, S. S. Kumar, R. Subhashini, A. Sathivel, and T. Devaki, “Synergistic interactions of ferulic acid with ascorbic acid: its cardioprotective role during isoproterenol induced myocardial infarction in rats,” Molecular and Cellular Biochemistry, vol. 283, no. 1-2, pp. 139–146, 2006. View at Publisher · View at Google Scholar · View at Scopus
  25. C. M. Diaz-Montero, M. L. Salem, M. I. Nishimura, E. Garrett-Mayer, D. J. Cole, and A. J. Montero, “Increased circulating myeloid-derived suppressor cells correlate with clinical cancer stage, metastatic tumor burden, and doxorubicin-cyclophosphamide chemotherapy,” Cancer Immunology, Immunotherapy, vol. 58, no. 1, pp. 49–59, 2009. View at Publisher · View at Google Scholar · View at Scopus
  26. M. M. Sayed-Ahmed, M. L. Aldelemy, O. A. Al-Shabanah et al., “Inhibition of gene expression of carnitine palmitoyltransferase I and heart fatty acid binding protein in cyclophosphamide and ifosfamide-induced acute cardiotoxic rat models,” Cardiovascular Toxicology, vol. 14, no. 3, pp. 232–242, 2014. View at Publisher · View at Google Scholar · View at Scopus
  27. I. Gil-Ortega and J. C. Kaski, “Diabetic miocardiopathy,” Medicina Clinica, vol. 127, no. 15, pp. 584–594, 2006. View at Publisher · View at Google Scholar · View at Scopus
  28. D. J. Conklin, P. Haberzettl, G. Jagatheesan et al., “Glutathione S-transferase P protects against cyclophosphamide-induced cardiotoxicity in mice,” Toxicology and Applied Pharmacology, vol. 285, no. 2, pp. 136–148, 2015. View at Publisher · View at Google Scholar
  29. B. Wei, M.-G. You, J.-J. Ling et al., “Regulation of antioxidant system, lipids and fatty acid beta-oxidation contributes to the cardioprotective effect of sodium tanshinone IIA sulphonate in isoproterenol-induced myocardial infarction in rats,” Atherosclerosis, vol. 230, no. 1, pp. 148–156, 2013. View at Publisher · View at Google Scholar · View at Scopus
  30. Y. Liu, D. Tan, L. Shi et al., “Blueberry anthocyanins-enriched extracts attenuate cyclophosphamide-induced cardiac injury,” PLoS ONE, vol. 10, no. 7, Article ID e0127813, 2015. View at Publisher · View at Google Scholar
  31. C. Ma, L. Zhu, J. Wang et al., “Anti-inflammatory effects of water extract of Taraxacum mongolicum hand.-Mazz on lipopolysaccharide-induced inflammation in acute lung injury by suppressing PI3K/Akt/mTOR signaling pathway,” Journal of Ethnopharmacology, vol. 168, pp. 349–355, 2015. View at Publisher · View at Google Scholar
  32. H. He, X. Chang, J. Gao, L. Zhu, M. Miao, and T. Yan, “Salidroside mitigates sepsis-induced myocarditis in rats by regulating IGF-1/PI3K/Akt/GSK-3β signaling,” Inflammation, vol. 38, no. 6, pp. 2178–2184, 2015. View at Publisher · View at Google Scholar
  33. T. Lou, W. Jiang, D. Xu, T. Chen, and Y. Fu, “Inhibitory effects of polydatin on lipopolysaccharide-stimulated RAW 264.7 cells,” Inflammation, vol. 38, no. 3, pp. 1213–1220, 2015. View at Publisher · View at Google Scholar · View at Scopus
  34. T. Chen, Q. Guo, H. Wang et al., “Effects of esculetin on lipopolysaccharide (LPS)-induced acute lung injury via regulation of RhoA/Rho Kinase/NF-κB pathways in vivo and in vitro,” Free Radical Research, vol. 49, no. 12, pp. 1459–1468, 2015. View at Publisher · View at Google Scholar
  35. T. Chen, Y. Mou, J. Tan et al., “The protective effect of CDDO-Me on lipopolysaccharide-induced acute lung injury in mice,” International Immunopharmacology, vol. 25, no. 1, pp. 55–64, 2015. View at Publisher · View at Google Scholar · View at Scopus
  36. W. Jing, M. Chunhua, and W. Shumin, “Effects of acteoside on lipopolysaccharide-induced inflammation in acute lung injury via regulation of NF-κB pathway in vivo and in vitro,” Toxicology and Applied Pharmacology, vol. 285, no. 2, pp. 128–135, 2015. View at Publisher · View at Google Scholar
  37. L. Zhu, T. Wei, X. Chang et al., “Effects of salidroside on myocardial injury in vivo in vitro via regulation of Nox/NF-κB/AP1 pathway,” Inflammation, vol. 38, no. 4, pp. 1589–1598, 2015. View at Publisher · View at Google Scholar · View at Scopus
  38. X. Chang, F. Luo, W. Jiang et al., “Protective activity of salidroside against ethanol-induced gastric ulcer via the MAPK/NF-κB pathway in vivo and in vitro,” International Immunopharmacology, vol. 28, no. 1, pp. 604–615, 2015. View at Publisher · View at Google Scholar
  39. A. Kis, D. M. Yellon, and G. F. Baxter, “Role of nuclear factor-κB activation in acute ischaemia-reperfusion injury in myocardium,” British Journal of Pharmacology, vol. 138, no. 5, pp. 894–900, 2003. View at Publisher · View at Google Scholar · View at Scopus
  40. S. D. Hingtgen, Z. Li, W. Kutschke, X. Tian, R. V. Sharma, and R. L. Davisson, “Superoxide scavenging and Akt inhibition in myocardium ameliorate pressure overload-induced NF-κB activation and cardiac hypertrophy,” Physiological Genomics, vol. 41, no. 2, pp. 127–136, 2010. View at Publisher · View at Google Scholar · View at Scopus
  41. S. Thakur, L. Li, and S. Gupta, “NF-κB-mediated integrin-linked kinase regulation in angiotensin II-induced pro-fibrotic process in cardiac fibroblasts,” Life Sciences, vol. 107, no. 1-2, pp. 68–75, 2014. View at Publisher · View at Google Scholar · View at Scopus